Page last updated: 2024-10-15

3-hydroxyisobutyric acid and Hepatitis C

3-hydroxyisobutyric acid has been researched along with Hepatitis C in 1 studies

3-hydroxyisobutyric acid: RN given refers to cpd without isomeric designation
3-hydroxyisobutyric acid : A 4-carbon, branched hydroxy fatty acid and intermediate in the metabolism of valine.

Hepatitis C: INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Biliotti, E1
Giampaoli, O1
Sciubba, F1
Marini, F1
Tomassini, A1
Palazzo, D1
Capuani, G1
Esvan, R1
Spaziante, M1
Taliani, G1
Miccheli, A1

Other Studies

1 other study available for 3-hydroxyisobutyric acid and Hepatitis C

ArticleYear
Urinary metabolomics of HCV patients with severe liver fibrosis before and during the sustained virologic response achieved by direct acting antiviral treatment.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2021, Volume: 143

    Topics: Aged; Antiviral Agents; Biomarkers; Hepatitis C; Humans; Hydroxybutyrates; Liver Cirrhosis; Male; Me

2021